Data as of Sep 19
| +0.83 / +2.07%|
The 7 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 43.00, with a high estimate of 75.00 and a low estimate of 37.00. The median estimate represents a +5.06% increase from the last price of 40.93.
The current consensus among 7 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.